Registration Dossier

Administrative data

Description of key information

The acute toxicity is driven by the characteristics of the individual UVCB constituents. 
Relevant information on the individual UVCB constituents is reported in Section 7 Summary.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
adverse effect observed

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
adverse effect observed

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Additional information

Justification for classification or non-classification

Acute toxicity oral route: Category 3 (general grade)

4 (grade 2)

Acute toxicity inhalation route: Category 2 (general grade)

4 (grade 2)

Acute toxicity dermal route: not classified

The tested sample is representative for a typical across industry (and worst-case), defined within the concentration ranges outlined under IUCLID section 1.2.

See IUCLID section 13 or CSR Annex 1 for detailed MeClas outprints with the specified input concentrations and resulting classification. Please visit www. meclas.eu for more information about the tool.